【康拓医疗：控股子公司取得第三类医疗器械注册证】康拓医疗公告称，公司控股子公司西安美妍天使生物技术有限公司近日取得国家药品监督管理局颁发的第三类《医疗器械注册证》，产品名称为注射用交联透明质酸钠凝胶，用于颈部皮内真皮层注射填充以纠正颈部中重度横纹，注册证有效期至2031年8月23日。本次获批标志公司向皮肤填充领域战略延伸取得实质性进展，将丰富产品类别、完善业务布局，增强消费医疗领域综合竞争力。产品未来业绩受市场拓展等因素影响，销售及利润贡献存在不确定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.